Buscar
Compugen Ltd
CGENAñadir a la lista de seguimiento
2.460USD
-0.020-0.81%
Cierre 09-10 16:00（ET）
232.55MCap. mercado
6.55P/E TTM
Fuera de horario (ET)0.000USD0.000
Fuera de horario (ET)Más Datos de Compugen Ltd Compañía
Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in areas of unmet medical needs in various cancer types and patient populations, both as monotherapy and in combination with other drugs. Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology, with emphasis on its discovery capabilities on immuno-oncology.
Perfil de Compugen Ltd
Símbolo de cotizaciónCGEN
Nombre de la empresaCompugen Ltd
Fecha de salida a bolsaAug 01, 2000
Director ejecutivoOphir (Eran)
Número de empleados74
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 01
DirecciónAzrieli Center
CiudadHOLON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísIsrael
Código postal5885849
Teléfono97237658585
Sitio Webhttps://cgen.com/
Símbolo de cotizaciónCGEN
Fecha de salida a bolsaAug 01, 2000
Director ejecutivoOphir (Eran)
Ejecutivos de Compugen Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Anat Cohen-Dayag, Ph.D.
Dr. Anat Cohen-Dayag, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
75.81K
+25.97%
Dr. Zurit Levine, Ph.D.
Dr. Zurit Levine, Ph.D.
Senior Vice President, Technology Innovation
Senior Vice President, Technology Innovation
47.38K
+37.99%
Mr. Gilead Halevy
Mr. Gilead Halevy
Independent Director
Independent Director
18.91K
+39.67%
Mr. Eran Ophir
Mr. Eran Ophir
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
11.38K
--
Dr. Kinneret Livnat Savitsky, Ph.D.
Dr. Kinneret Livnat Savitsky, Ph.D.
Independent Director
Independent Director
--
--
Mr. Paul Jai Sekhri
Mr. Paul Jai Sekhri
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Sanford (Sandy) Zweifach, CPA
Mr. Sanford (Sandy) Zweifach, CPA
Independent Director
Independent Director
--
--
Mr. Eran Perry
Mr. Eran Perry
Independent Director
Independent Director
--
--
Dr. Oliver Froescheis, Ph.D.
Dr. Oliver Froescheis, Ph.D.
Senior Vice President, Corporate and Business Development
Senior Vice President, Corporate and Business Development
--
--
Dr. Yaron Turpaz, Ph.D.
Dr. Yaron Turpaz, Ph.D.
Senior Vice President, Senior Advisor, Computational Discovery
Senior Vice President, Senior Advisor, Computational Discovery
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Anat Cohen-Dayag, Ph.D.
Dr. Anat Cohen-Dayag, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
75.81K
+25.97%
Dr. Zurit Levine, Ph.D.
Dr. Zurit Levine, Ph.D.
Senior Vice President, Technology Innovation
Senior Vice President, Technology Innovation
47.38K
+37.99%
Mr. Gilead Halevy
Mr. Gilead Halevy
Independent Director
Independent Director
18.91K
+39.67%
Mr. Eran Ophir
Mr. Eran Ophir
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
11.38K
--
Dr. Kinneret Livnat Savitsky, Ph.D.
Dr. Kinneret Livnat Savitsky, Ph.D.
Independent Director
Independent Director
--
--
Mr. Paul Jai Sekhri
Mr. Paul Jai Sekhri
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Compugen Ltd?
Los cinco principales accionistas de Compugen Ltd son: Dr. Anat Cohen-Dayag, Ph.D.
¿Cuántas instituciones poseen acciones de Compugen Ltd (CGEN)?
A fecha de 2026Q1, 124 instituciones poseen acciones de Compugen Ltd, con un valor de mercado combinado de aproximadamente 13.75M, lo que representa el 14.54% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 445223.00.